Leadership Overview
Bharat Serums And Vaccines has 10 executives leading key functions including domestic operations, financial oversight, international expansion, quality assurance, and medical strategy.
Focused on advancing biopharmaceutical innovation, Bharat Serums And Vaccines delivers life-saving treatments across women's health and critical care sectors to improve global patient outcomes.
Focused on advancing biopharmaceutical innovation, Bharat Serums And Vaccines delivers life-saving treatments across women's health and critical care sectors to improve global patient outcomes.
Leadership Roles at Bharat Serums And Vaccines
Pragati Maheshwari - Chief Financial Officer, Internal Audit & Projects, Office
Pragati Maheshwari, the Chief Financial Officer, Internal Audit & Projects, Office at Bharat Serums And Vaccines, manages the fiscal health and strategic project governance of the enterprise. Overseeing internal audit protocols, the Chief Financial Officer, Internal Audit & Projects, Office ensures absolute compliance with regulatory standards while identifying opportunities for operational cost reduction. This leadership role involves evaluating capital allocation for research and development initiatives, directly supporting the company's commitment to biotech innovation. By maintaining transparent financial reporting, Pragati Maheshwari provides the board with actionable insights necessary for long-term planning. Additionally, the Chief Financial Officer, Internal Audit & Projects, Office coordinates cross-functional project teams to streamline internal processes, thereby enhancing organizational agility. Through meticulous oversight of corporate assets and risk management frameworks, the Chief Financial Officer, Internal Audit & Projects, Office safeguards the financial integrity of the firm, ensuring resources remain focused on delivering positive health outcomes for patients globally.
Sivani Deka - Chief Operating Officer, Business (India)
Sivani Deka, the Chief Operating Officer, Business (India) at Bharat Serums And Vaccines, directs all domestic commercial activities and market penetration strategies. Overseeing the entire Indian portfolio, the Chief Operating Officer, Business (India) ensures seamless integration between manufacturing output and regional distribution networks. This leadership role involves optimizing supply chain efficiency to meet the rising demand for critical care and women's health products across the subcontinent. By aligning internal resources with evolving market needs, Sivani Deka directly impacts the company's domestic growth trajectory. Furthermore, the Chief Operating Officer, Business (India) maintains rigorous standards for product accessibility, ensuring that life-saving biopharmaceuticals reach healthcare providers efficiently. Through constant monitoring of regional performance metrics, the Chief Operating Officer, Business (India) secures a competitive advantage within the complex Indian pharmaceutical landscape, ultimately driving sustainable revenue expansion and strengthening the overall market position of the organization.
Rahul Adakmol - Chief Operating Officer, International Business
Rahul Adakmol, the Chief Operating Officer, International Business at Bharat Serums And Vaccines, architects the global expansion strategy for the company's diverse biopharmaceutical portfolio. Overseeing international market entry, the Chief Operating Officer, International Business drives the adoption of assisted reproductive technology and critical care solutions across diverse regulatory environments. This leadership role involves building robust partnerships with global distributors to ensure consistent product availability in emerging markets. By analyzing international healthcare trends, Rahul Adakmol identifies high-growth regions for strategic investment, effectively scaling the company's footprint beyond domestic borders. Furthermore, the Chief Operating Officer, International Business coordinates with global regulatory bodies to navigate complex compliance requirements, facilitating smooth product launches. Through the implementation of standardized operational procedures across international territories, the Chief Operating Officer, International Business optimizes global supply chain logistics, ensuring that the company's commitment to saving lives remains consistent regardless of geographic location or local market challenges.
Manisha Khanivdekar - Executive Assistant To Chief Operating Officer, Sr. Vice President and President
Manisha Khanivdekar, the Executive Assistant To Chief Operating Officer, Sr. Vice President and President at Bharat Serums And Vaccines, facilitates high-level executive coordination and strategic communication across the leadership team. Overseeing administrative workflows for senior management, the Executive Assistant To Chief Operating Officer, Sr. Vice President and President ensures that critical operational priorities receive immediate attention. This leadership role involves managing complex schedules and cross-departmental projects that support the company's mission of advancing biopharmaceutical research. By acting as a central point of contact for the executive office, Manisha Khanivdekar streamlines decision-making processes and enhances organizational efficiency. Furthermore, the Executive Assistant To Chief Operating Officer, Sr. Vice President and President prepares essential documentation for board meetings, ensuring that leadership remains informed on key performance indicators. Through meticulous attention to detail and proactive management of executive communications, the Executive Assistant To Chief Operating Officer, Sr. Vice President and President supports the seamless execution of corporate strategy across all therapeutic areas.
Shailesh Pednekar - Chief Operating Officer, International Business
Shailesh Pednekar, the Chief Operating Officer, International Business at Bharat Serums And Vaccines, focuses on the operational scaling of international manufacturing and distribution networks. Overseeing the logistics of global product delivery, the Chief Operating Officer, International Business ensures that the company's biotech products meet international quality standards upon arrival in foreign markets. This leadership role involves optimizing the efficiency of international supply chains to reduce lead times for critical care medications. By leveraging data-driven insights, Shailesh Pednekar refines operational workflows to support the company's aggressive growth targets in overseas territories. Furthermore, the Chief Operating Officer, International Business collaborates with regional managers to adapt operational strategies to local market nuances, ensuring that the company maintains a strong presence in competitive global sectors. Through the continuous improvement of international operational infrastructure, the Chief Operating Officer, International Business secures the reliability of the global supply chain, directly contributing to the company's ability to save lives on a worldwide scale.
Jaby Jacob - Senior President
Jaby Jacob, the Senior President at Bharat Serums And Vaccines, provides high-level strategic direction for the company's long-term growth and market positioning. Overseeing broad organizational initiatives, the Senior President ensures that all business units remain aligned with the core mission of developing innovative biopharmaceutical products. This leadership role involves fostering a culture of research and development excellence, supporting the company's 50-year legacy of medical advancement. By evaluating macro-level industry trends, Jaby Jacob guides the firm through evolving market landscapes, ensuring that the company remains at the forefront of the biotech sector. Furthermore, the Senior President coordinates with other C-suite leaders to integrate operational goals with financial targets, driving sustainable profitability. Through the promotion of strategic partnerships and the expansion of the company's therapeutic reach, the Senior President secures the organization's future as a leader in critical care and women's health, consistently delivering positive health outcomes for patients worldwide.
Sanjeeb Mishra - President, Quality
Sanjeeb Mishra, the President, Quality at Bharat Serums And Vaccines, establishes and enforces the rigorous quality management systems required for biopharmaceutical manufacturing. Overseeing global quality assurance, the President, Quality ensures that every product leaving the facility meets stringent international safety and efficacy standards. This leadership role involves auditing manufacturing processes to identify and mitigate potential risks, thereby protecting the company's reputation for excellence. By implementing advanced quality control technologies, Sanjeeb Mishra maintains the integrity of the supply chain from raw material procurement to final delivery. Furthermore, the President, Quality collaborates with regulatory agencies to ensure continuous compliance with evolving global health standards. Through the cultivation of a quality-first culture across all departments, the President, Quality safeguards the health of patients and supports the company's commitment to delivering reliable, life-saving treatments. This dedication to quality remains a cornerstone of the company's operational success and its ability to maintain trust within the global medical community.
Rudradev Mukherjee - President, International Business
Rudradev Mukherjee, the President, International Business at Bharat Serums And Vaccines, leads the strategic vision for the company's expansion into diverse global markets. Overseeing international commercial strategy, the President, International Business identifies new opportunities for the company's biotech and pharmaceutical products in regions outside of India. This leadership role involves negotiating high-level partnerships and navigating the complexities of international healthcare regulations to ensure successful market entry. By analyzing global demand for critical care and women's health solutions, Rudradev Mukherjee directs the allocation of resources to maximize international revenue growth. Furthermore, the President, International Business coordinates with regional teams to ensure that the company's brand remains consistent and competitive on a global stage. Through the execution of long-term international growth strategies, the President, International Business strengthens the company's global footprint, ensuring that innovative treatments reach patients in need across multiple continents, thereby fulfilling the organization's mission of improving health outcomes worldwide.
Lakhiram Petwal - President, Operations
Lakhiram Petwal, the President, Operations at Bharat Serums And Vaccines, manages the end-to-end manufacturing and operational infrastructure of the company. Overseeing production facilities, the President, Operations ensures that the company's biopharmaceutical products are manufactured with maximum efficiency and precision. This leadership role involves optimizing manufacturing capacity to meet the global demand for critical care and assisted reproductive technology. By integrating advanced automation and process improvements, Lakhiram Petwal enhances the scalability of the company's production lines. Furthermore, the President, Operations collaborates with the research and development team to transition new products from the laboratory to full-scale commercial manufacturing. Through the rigorous management of operational resources and the implementation of lean manufacturing principles, the President, Operations drives cost-effectiveness and reliability across the entire production cycle. This focus on operational excellence ensures that the company can consistently deliver high-quality treatments to patients, supporting the overall mission of saving lives through innovative pharmaceutical solutions.
Swashraya Shah - Chief Medical Officer
Swashraya Shah, the Chief Medical Officer at Bharat Serums And Vaccines, directs the clinical strategy and medical oversight for the company's entire therapeutic portfolio. Overseeing clinical trials and medical affairs, the Chief Medical Officer ensures that all pharmaceutical developments align with the highest standards of patient safety and efficacy. This leadership role involves guiding the team of over 60 scientists in the pursuit of innovative treatments for women's health and assisted reproductive technology. By interpreting complex clinical data, Swashraya Shah provides the scientific foundation for new product launches and regulatory submissions. Furthermore, the Chief Medical Officer engages with the global medical community to advocate for the company's therapeutic solutions, ensuring that healthcare providers understand the clinical benefits of the firm's offerings. Through rigorous scientific leadership and a commitment to evidence-based medicine, the Chief Medical Officer drives the development of life-saving treatments, ultimately enhancing the quality of life for patients across the globe.
Explore Leadership Teams in Manufacturing
Abbott is a global healthcare company that develops and delivers a broad range of medical technologies, diagnostics, nutrition products, and branded generic medicines. The company is focused on improving health outcomes and helping people live healthier lives across all stages of life. Its mission centers on creating innovative solutions that address important medical needs, including chronic disease management, cardiovascular care, diabetes care, and pain management.
Company Leadership RH
RT
CA
Boehringer Ingelheim is a privately held, research-driven pharmaceutical company headquartered in Ingelheim am Rhein, Germany, founded in 1885. The company researches, develops, and manufactures prescription medicines and healthcare products across three core business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Its primary therapeutic focus areas include respiratory diseases, oncology, immunology, cardiometabolic conditions, and central nervous system disorders. Boehringer Ingelheim also develops and manufactures veterinary products for companion animals, livestock, and poultry. Operating in over 100 countries with more than 53,000 employees globally, the company maintains a broad network of research, manufacturing, and commercial sites across Europe, North America, and Asia. It is one of the largest privately owned pharmaceutical companies in the world.
Company Leadership KE
KY
DP
PL
At Simtra, the company is dedicated to developing and manufacturing quality sterile injectable products to meet evolving patient needs. The company works with precision and transparency, setting high standards and paying attention to every detail, in order to ensure that the company makes your product right the first time, deliver it on time and meet your requirements in full. The company is made for this, with the company's extensive slate of services and product delivery options.
Company Leadership



Hemofarm is the leading pharmaceutical company in Serbia and in the region. Care for your health is the company's most important commitment. Hemofarm is a leader in the Serbian pharmaceutical market with a 17.3% share in financial terms. Holding a 79.1% share in the export of Serbian pharmaceutical products, the Vrac-based company is at the same time the leading Serbian exporter of medicinal products. Hemofarm produces over 4 billion tablets and capsules a year.
Company Leadership DS
TM
VA